Form 4: Compugen SVP Sells Shares After Option Exercise

Compugen's SVP of Business Development, Zurit Levine, exercised options and subsequently sold 11,875 ordinary shares under a pre-arranged trading plan.

Summary

• Zurit Levine, SVP of Business Development at Compugen Ltd., reported transactions involving the company's ordinary shares.
• On March 26, 2026, Levine exercised 11,875 share options at an exercise price of $0.8292 per share.
• Concurrently, Levine sold 11,875 ordinary shares at a weighted average price of $2.0368 per share, with individual sales ranging from $2.02 to $2.10.
• These transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted by Levine on December 23, 2025.
• Following these transactions, Levine directly beneficially owns 29,375 ordinary shares.
• Levine also holds 16,125 derivative share options, which vested 25% on December 31, 2023, with the remainder vesting in 12 equal quarterly installments thereafter, subject to continued service.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral to slightly negative event. While the sale was pre-planned via a 10b5-1 plan, mitigating immediate negative sentiment, it still represents an insider reducing their stake. The exercise of options at a lower price and subsequent sale at a higher price is a common practice for executive compensation.

Positives

• The exercise of options indicates that the insider found value in acquiring shares at the exercise price.
• The transactions were executed under a Rule 10b5-1 trading plan, suggesting a pre-planned sale rather than a reaction to immediate negative news.

Negatives

• An insider, the SVP of Business Development, sold a significant number of shares, reducing their direct equity stake in the company.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly sales, are closely watched by investors for signals about management's confidence in the company's future. While a sale under a Rule 10b5-1 plan suggests a pre-determined liquidity event rather than a reaction to new information, it still represents a reduction in an executive's direct equity exposure to Compugen Ltd. This type of transaction is common across industries as executives manage personal finances and diversify portfolios.

Stakeholder Impact

• Shareholders may interpret the insider sale as a signal, though the 10b5-1 plan suggests it's not based on new, undisclosed information.

Key Dates

Keywords

Compugen Ltd, CGEN, Insider Trading, Form 4, Stock Options, Share Sale, Rule 10b5-1, Zurit Levine, SVP Business Development